Journal profile

Rejuvenation research

Publisher: SAGE Publications
ISSN1549-1684 | 1557-8577 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.76
Citation rate 1.87 107 total citations
h5-index 19 h5 depth signal
Cited share 54.0% 34 of 63
Total citations 107 Citation footprint
Metric signal 2.09 External metric anchor
Self-citation 0.9% 1 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 154
United States 144
Italy 38
India 33
United Kingdom 25

Citing Fields of Research

Aging & Longevity 235
Neurodegenerative Disorders 73
Stem Cell Biology 49
Musculoskeletal Disorders 36
DNA Damage 33

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 1,633 Articles tracked across the journal lifetime
Indexed publication set 63 34 cited publications
Last 12 months 43 4.3 publications/month
Open access share 4.7% 2 OA publications in the last year
Leading citing country China 154 citing publications
Leading citing field Aging & Longevity 235 citing publications
Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v7n1, spring 2004-
PubMed
v7n1, spring 2004-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Aging & Longevity Musculoskeletal Disorders Neurodegenerative Disorders Diabetes Cardiology Cancer, Autophagy & Apoptosis

Broad Categories

Geriatrics Physiology Aging & Longevity Musculoskeletal Disorders Neurodegenerative Disorders Cancer, Autophagy & Apoptosis Hematology Nutrition & Dietetics Genetics & Genomics

MeSH Descriptors

Aging Longevity Rejuvenation

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

03
Chun-Ru Lin, Po-An Tsai, Jing-Yi Chen et al.
Gait speed is a key indicator for diagnosing sarcopenia, validated by both the European Working Group on Sarcopenia in Older People in 2018 and the Asian Working Group on Sarcopenia in 2019 for assessing physical performance. While globa...
04
Ying Zhang, Yan Li
Falls impose a major public health burden on middle-aged and older adults. Coexisting cardiovascular disease (CVD) and arthritis further increases fall risk, yet targeted prediction models remain scarce, especially in Chinese populations...
06
Adiv A. Johnson
Biological age describes how a person is aging on molecular, cellular, and physiological levels. At the present time, biological age is not something that can be fully quantified and aging itself is far too complicated to be captured by ...
08
Zhihua Hao, Tianwei Meng, Songzhe Li et al.
Mild cognitive impairment (MCI) lacks approved disease-modifying therapies. Classical multicomponent prescriptions may act on convergent neurobiological nodes. We combined network pharmacology with in vivo testing to evaluate Yizhi Dihua...
09
Amy Hai Yan Chan, Kebede Beyene, Bertha Lai et al.
Metformin use may be associated with reduced risk of all-cause mortality as well as prevent the onset of diseases of aging, namely cardiovascular diseases (CVD), cancer, and dementia. We systematically reviewed recent studies to determin...

Bibliographical & Catalog Notes

Title from cover.

Also issued online.